Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
To assess at baseline and after treatment administration the severity of the illness in patients with schizophrenia, using the scores obtained after the application of the CGI scale
To assess the changes in symptoms of patients treated with Seroquel for 24 weeks, using BPRS (Brief Psychiatry Rating Scale) as measuring tool
You may not be if
All the patients who have a known hypersensitivity to Seroquel /quetiapine or any of its excipients will not be included in this study.
Clareo Health | Seroquel (Quetiapine Fumarate) InPractice Evaluation Programme
